The global Gastrointestinal Stromal Tumor (GIST) market is entering a transformative phase in 2025. As a rare but significant subset of soft tissue sarcomas, GISTs have become a hallmark for the success of precision oncology. By leveraging specific genetic insights, the market is shifting from broad-spectrum treatments to highly targeted molecular therapies. https://www.databridgemarketresearch.com/reports/global-gastrointestinal-stromal-tumor-market